SynthesisFrontiers in immunology2023

Clinical benefits of PD-1 inhibitors in specific subgroups of patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of phase 3 randomized clinical trials.

Yao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.